Skip to content
← Holders

Nextech Invest Ltd.

What Nextech Invest Ltd. reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1595430 · Filed Nov 16, 2026

Positions
18
Reported value
$2.2B
Opened
4
Closed
2
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$657M
    15 positions
  2. Dec 31, 2025$1B
    16 positions
  3. Mar 31, 2026$1.4B
    17 positions
  4. Jun 30, 2026$2.1B
    16 positions
  5. Sep 30, 2026$2.2B
    18 positions
SecuritySharesChangeValueOf portfolio
RVMDRevolution Medicines, Inc.
7.6M±0%$1.6B69.9%
PBLSParabilis Medicines, Inc.
4.7M±0%$150.6M6.7%
RLAYRelay Therapeutics, Inc.
6.8M±0%$122.3M5.5%
ORICOric Pharmaceuticals, Inc.
7.2M±0%$96.5M4.3%
TYRATyra Biosciences, Inc.
3.4M−3.0%$75.4M3.4%
ALMSAlumis Inc.
4.6M+28.5%$33.6M1.5%
ATTOAttovia Therapeutics, Inc.
1.8MNew$31.5M1.4%
KYMRKymera Therapeutics, Inc.
278.9K±0%$31.2M1.4%
ETRAElectra Therapeutics, Inc.
2.6MNew$29.7M1.3%
ZYMEZymeworks Inc.
1.1M±0%$29.5M1.3%
SLNSilence Therapeutics plc
1.7M+77.8%$18.5M0.8%
CTMXCytomX Therapeutics, Inc.
4.4M±0%$12.1M0.5%
AVTXAvalo Therapeutics, Inc.
766KNew$11.7M0.5%
GLUEMonte Rosa Therapeutics, Inc.
761.2K±0%$9.1M0.4%
BRVEBraveheart Bio, Inc.
416.7KNew$8.4M0.4%
CRVSCorvus Pharmaceuticals, Inc.
450K±0%$5.2M0.2%
ENGNenGene Therapeutics Inc.
2.3M±0%$4.6M0.2%
CNTXContext Therapeutics Inc.
7.4M±0%$2.2M0.1%